← Back to Search

MotionSense Wearable for Patient Engagement (FS5 Trial)

N/A
Waitlist Available
Led By Paul B Jacob, DO
Research Sponsored by Orthosensor, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days preoperative to 90 days postoperative
Awards & highlights

FS5 Trial Summary

This trialtested how well patients stick to their post-surgery rehab plan using a wearable device.

Eligible Conditions
  • Patient Engagement
  • Patient Reported Outcome Measures
  • Total Knee Arthroplasty

FS5 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preoperative, 1-30 days postoperative, 31-60 days postoperative, 61-90 days postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and preoperative, 1-30 days postoperative, 31-60 days postoperative, 61-90 days postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Document Home Exercise Program Prescribed to Patients Throughout Their Individualized Recovery Progress by Surgeons and Physiotherapists
Evaluate Patient and Practice Compliance With the MotionSense Wearable System: Filled Out Questionnaires
Evaluate Patient and Practice Compliance With the MotionSense Wearable System: Home Exercise Program
+3 more
Secondary outcome measures
Correlate Functional and Patient Reported Outcome Metrics
Establish Normative Recovery Data for the Metrics Captured by the MotionSense System: Daily Steps
Establish Normative Recovery Data for the Metrics Captured by the MotionSense System: Daily VAS Pain Scores
+6 more

FS5 Trial Design

1Treatment groups
Experimental Treatment
Group I: MotionSense WearableExperimental Treatment1 Intervention
Using MotionSense from pre-op to 90 days post-op during the recovery after primary TKA
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MotionSense
2021
N/A
~110

Find a Location

Who is running the clinical trial?

Orthosensor, Inc.Lead Sponsor
8 Previous Clinical Trials
1,121 Total Patients Enrolled
Paul B Jacob, DOPrincipal InvestigatorOJRI

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Limited Market Release - MotionSense Clinical Use Evaluation
2021. "Limited Market Release - MotionSense Clinical Use Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05091918.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top